Pri-Med Heart Failure : State of the Art 2015
WebcastFaculty
OVERVIEW
Pri-Med Heart Failure : State of the Art 2015 is organized by Pri-Med and will be held during Aug 06, 2015 - Aug 06, 2018.
The target audience for this medical event is Cardiologists. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits.
Overview :
Heart failure (HF) affects over 5 million Americans, with 825,000 new cases occurring annually and a resultant 1,000,000 hospitalizations, which translates into an annual estimated cost of over $30 billion dollars. Implementation of the advances in management of heart failure have the potential to improve patients' quality of life, reduce the need for hospitalizations, reduce total medical costs, and prolong survival. This activity will review the current evidence-based, guideline recommended diagnosis and management of heart failure. Dr. Fonarow, a leading expert in Cardiovascular Medicine will discuss the essential roles of evidence-based heart failure medications, device therapy, patient education, and disease management.
Learning Objectives :
• Outline the prevalence, risk factors for, diagnosis, and prognosis with heart failure
• Describe current evidence-based guideline recommendations for heart failure therapy
• Describe the impact of medical therapies on heart failure patient outcome
• Highlight the benefits of device therapy and disease management for heart failure
Additional details will be posted as soon as they are available.
The target audience for this medical event is Cardiologists. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits.
Overview :
Heart failure (HF) affects over 5 million Americans, with 825,000 new cases occurring annually and a resultant 1,000,000 hospitalizations, which translates into an annual estimated cost of over $30 billion dollars. Implementation of the advances in management of heart failure have the potential to improve patients' quality of life, reduce the need for hospitalizations, reduce total medical costs, and prolong survival. This activity will review the current evidence-based, guideline recommended diagnosis and management of heart failure. Dr. Fonarow, a leading expert in Cardiovascular Medicine will discuss the essential roles of evidence-based heart failure medications, device therapy, patient education, and disease management.
Learning Objectives :
• Outline the prevalence, risk factors for, diagnosis, and prognosis with heart failure
• Describe current evidence-based guideline recommendations for heart failure therapy
• Describe the impact of medical therapies on heart failure patient outcome
• Highlight the benefits of device therapy and disease management for heart failure
Additional details will be posted as soon as they are available.
SPECIALITIES
CardiologyPrimary Care
Quick Links